Skip to main content
. 2021 Sep 16;190(2):307–315. doi: 10.1007/s10549-021-06351-z

Table 1.

Closed-ended scaled-response questions with answers ranging from 1 (strongly disagree) to 5 (strongly agree)

Statements 1 2 3 4 5
Women without a pathogenic variant, n = 23
 I understood the written information that I obtained regarding the study 5 (21.7%) 18 (78.3%)
 I am satisfied with the obtained written information regarding the study and the opportunity for further contacts 3 (13.0%) 20 (87.0%)
 I would have wished for additional oral information 13 (56.5%) 4 (17.4%) 5 (21.7%) 1 (4.3%)
 I am satisfied with undergoing genetic testing 1 (4.3%) 22 (95.7%)
 I have shared the information that I obtained with my relatives 2 (8.7%) 2 (8.7%) 2 (8.7%) 17 (73.9%)
 I would recommend a female friend with breast cancer to undergo genetic testing in the same way that I did 3 (13.0%) 2 (8.7%) 18 (78.3%)
Women with a pathogenic variant, n = 4
 I understood the written information that I obtained regarding the study 1 (25.0%) 3 (75.0%)
 I am satisfied with the obtained written information regarding the study and the opportunity for further contacts 4 (100.0%)
 I would have wished for additional oral information 4 (100.0%)
 I am satisfied with undergoing genetic testing 4 (100.0%)
 I have shared the information that I obtained with my relatives 1 (25.0%) 3 (75.0%)
 I would recommend a female friend with breast cancer to undergo genetic testing in the same way that I did 1 (25.0%) 3 (75.0%)

Most frequent answers are highlighted in bold